Energy and Commerce Committee Republican members indicate particular concern with knowing how hospitals use drug discount savings to improve patient care.
Hospitals and other health care providers benefitting from 340B drug pricing should be required to report how they apply savings from the deep discounts accessed through the program, House Energy and Commerce Health Subcommittee members maintained at a March 24 hearing.
Under the program, safety net health care providers can receive Medicaid-level or deeper discounts on drugs. The legislators suggested that...
US FDA critics have long decried the practice of using informal communications to convey regulatory expectations as podium policy. In the Makary era, the phrase may need to be updated because the agency now seems to be specializing in policy by podcast.
Tala Fakhouri said the agency’s use of the AI tool in the review process has generated lots of questions.
Kumar takes over as acting director of the Center for Biologics Evaluation and Research’s Office of Therapeutic Products days after director Nicole Verdun was ousted.
Recent and upcoming US FDA advisory committee meetings and a summary of the topics covered.
